Interaction between MUC1 and STAT1 drives IFITM1 overexpression in aromatase inhibitor-resistant breast cancer cells

被引：1
|
作者：
Lui, Asona
Lewis-Wambi, Joan
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2918
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis
    Escher, Taylor E.
    Lui, Asona J.
    Geanes, Eric S.
    Waller, Katherine R.
    Tawfik, Ossama
    Hagan, Christy R.
    Lewis-Wambi, Joan
    MOLECULAR CANCER RESEARCH, 2019, 17 (05) : 1180 - 1194
  • [2] Disrupting MUC1/IFITM1 crosstalk reverses the aggressive phenotype of aromatase inhibitor-resistant breast cancer
    Escher, Taylor E.
    Geanes, Eric
    Lui, Asona
    Lewis-Wambi, Joan
    CANCER RESEARCH, 2018, 78 (13)
  • [3] IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21
    Lui, Asona J.
    Geanes, Eric S.
    Ogony, Joshua
    Behbod, Fariba
    Marquess, Jordan
    Valdez, Kelli
    Jewell, William
    Tawfik, Ossama
    Lewis-Wambi, Joan
    CANCER LETTERS, 2017, 399 : 29 - 43
  • [4] Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
    Khodarev, N.
    Ahmad, R.
    Rajabi, H.
    Pitroda, S.
    Kufe, T.
    McClary, C.
    Joshi, M. D.
    MacDermed, D.
    Weichselbaum, R.
    Kufe, D.
    ONCOGENE, 2010, 29 (06) : 920 - 929
  • [5] Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer
    N Khodarev
    R Ahmad
    H Rajabi
    S Pitroda
    T Kufe
    C McClary
    M D Joshi
    D MacDermed
    R Weichselbaum
    D Kufe
    Oncogene, 2010, 29 : 920 - 929
  • [6] IFITM1 overexpression enhances the aggressive phenotype of inflammatory breast cancer in a STAT2-dependent manner
    Ogony, Joshua Were
    Lewis-Wambi, Joan
    CANCER RESEARCH, 2015, 75
  • [7] AIB1:ERα Transcriptional Activity Is Selectively Enhanced in Aromatase Inhibitor-Resistant Breast Cancer Cells
    O'Hara, Jane
    Vareslija, Damir
    McBryan, Jean
    Bane, Fiona
    Tibbitts, Paul
    Byrne, Christopher
    Conroy, Ronan M.
    Hao, Yuan
    Gaora, Peadar O.
    Hill, Arnold D. K.
    McIlroy, Marie
    Young, Leonie S.
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3305 - 3315
  • [8] Overexpression of interferon-stimulated genes is critical for the survival of aromatase inhibitor-resistant breast cancer cells
    Lui, Asona
    Choi, Hye-Joung
    Lewis-Wambi, Joan
    CANCER RESEARCH, 2015, 75
  • [9] Overexpression of MUC1 predicts poor prognosis in patients with breast cancer
    Jing, Xuan
    Liang, Hongping
    Hao, Chonghua
    Yang, Xiaojuan
    Cui, Xiangrong
    ONCOLOGY REPORTS, 2019, 41 (02) : 801 - 810
  • [10] STAT-1 activation enhances phospholipid scramblase 1-mediated apoptosis in aromatase inhibitor resistant breast cancer cells
    Brewer, Charlene
    Jan, Rifat
    Smith, Analese
    King, Tabitha
    Sims, Peter J.
    Lewis-Wambi, Joan S.
    CANCER RESEARCH, 2012, 72
12345